SVRA
Price
$5.89
Change
-$0.11 (-1.83%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
1.22B
70 days until earnings call
Intraday BUY SELL Signals
VYGR
Price
$3.83
Change
-$0.30 (-7.26%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
229.63M
54 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

SVRA vs VYGR

Header iconSVRA vs VYGR Comparison
Open Charts SVRA vs VYGRBanner chart's image
Savara
Price$5.89
Change-$0.11 (-1.83%)
Volume$22.15K
Capitalization1.22B
Voyager Therapeutics
Price$3.83
Change-$0.30 (-7.26%)
Volume$20.04K
Capitalization229.63M
SVRA vs VYGR Comparison Chart in %
SVRA
Daily Signal:
Gain/Loss:
VYGR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
SVRA vs. VYGR commentary
Jan 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SVRA is a Hold and VYGR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 16, 2026
Stock price -- (SVRA: $6.00 vs. VYGR: $4.13)
Brand notoriety: SVRA and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SVRA: 54% vs. VYGR: 361%
Market capitalization -- SVRA: $1.22B vs. VYGR: $229.63M
SVRA [@Biotechnology] is valued at $1.22B. VYGR’s [@Biotechnology] market capitalization is $229.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SVRA’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • SVRA’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, VYGR is a better buy in the long-term than SVRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SVRA’s TA Score shows that 3 TA indicator(s) are bullish while VYGR’s TA Score has 5 bullish TA indicator(s).

  • SVRA’s TA Score: 3 bullish, 5 bearish.
  • VYGR’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, VYGR is a better buy in the short-term than SVRA.

Price Growth

SVRA (@Biotechnology) experienced а +3.99% price change this week, while VYGR (@Biotechnology) price change was +0.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.44%. For the same industry, the average monthly price growth was +2.31%, and the average quarterly price growth was +42.34%.

Reported Earning Dates

SVRA is expected to report earnings on Mar 26, 2026.

VYGR is expected to report earnings on Mar 10, 2026.

Industries' Descriptions

@Biotechnology (-0.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SVRA($1.22B) has a higher market cap than VYGR($230M). VYGR YTD gains are higher at: 5.089 vs. SVRA (-0.498). SVRA has higher annual earnings (EBITDA): -120.38M vs. VYGR (-136.19M). SVRA has more cash in the bank: 124M vs. VYGR (45.1M). SVRA has less debt than VYGR: SVRA (29.8M) vs VYGR (38.4M). VYGR has higher revenues than SVRA: VYGR (31.3M) vs SVRA (0).
SVRAVYGRSVRA / VYGR
Capitalization1.22B230M532%
EBITDA-120.38M-136.19M88%
Gain YTD-0.4985.089-10%
P/E RatioN/A6.00-
Revenue031.3M-
Total Cash124M45.1M275%
Total Debt29.8M38.4M78%
FUNDAMENTALS RATINGS
SVRA vs VYGR: Fundamental Ratings
SVRA
VYGR
OUTLOOK RATING
1..100
5065
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
47
Fair valued
PROFIT vs RISK RATING
1..100
37100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
3663
P/E GROWTH RATING
1..100
1009
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VYGR's Valuation (47) in the Biotechnology industry is in the same range as SVRA (69). This means that VYGR’s stock grew similarly to SVRA’s over the last 12 months.

SVRA's Profit vs Risk Rating (37) in the Biotechnology industry is somewhat better than the same rating for VYGR (100). This means that SVRA’s stock grew somewhat faster than VYGR’s over the last 12 months.

VYGR's SMR Rating (97) in the Biotechnology industry is in the same range as SVRA (98). This means that VYGR’s stock grew similarly to SVRA’s over the last 12 months.

SVRA's Price Growth Rating (36) in the Biotechnology industry is in the same range as VYGR (63). This means that SVRA’s stock grew similarly to VYGR’s over the last 12 months.

VYGR's P/E Growth Rating (9) in the Biotechnology industry is significantly better than the same rating for SVRA (100). This means that VYGR’s stock grew significantly faster than SVRA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SVRAVYGR
RSI
ODDS (%)
Bearish Trend 2 days ago
73%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 14 days ago
82%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
SVRA
Daily Signal:
Gain/Loss:
VYGR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MRAAF21.650.37
+1.72%
Murata Manufacturing Inc.
BKAHF0.70N/A
N/A
Bank of Ayudhya Public Co. Ltd.
GCAAF48.43N/A
N/A
Guardian Capital Group Ltd.
NRSAF0.57N/A
N/A
Norse Atlantic ASA
RHCO0.02N/A
-17.03%
Readen Holding Corp.

SVRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SVRA has been loosely correlated with RCKT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if SVRA jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SVRA
1D Price
Change %
SVRA100%
+1.35%
RCKT - SVRA
60%
Loosely correlated
+4.21%
PRTA - SVRA
50%
Loosely correlated
+2.45%
RGNX - SVRA
37%
Loosely correlated
-0.66%
OCUL - SVRA
37%
Loosely correlated
+6.14%
VYGR - SVRA
36%
Loosely correlated
+2.74%
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with KURA. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
+2.74%
KURA - VYGR
55%
Loosely correlated
+1.63%
RGNX - VYGR
55%
Loosely correlated
-0.66%
XNCR - VYGR
54%
Loosely correlated
+3.66%
IMNM - VYGR
52%
Loosely correlated
+3.08%
IMTX - VYGR
50%
Loosely correlated
+4.80%
More